Public-domain · open source
OpenJurist
← 960 F. Supp. 2d 700 - Prather v. Abbot Laboratories

960 F. Supp. 2d 700 - Prather v. Abbot Laboratories’s Empirical Analysis

2013

Citation profile

7
cited by 7 later decisions
October 2018
most recently cited

1 district ·

Relationships

Applies 21 U.S.C. § 355 (Federal Food, Drug, and Cosmetic Act) · 21 U.S.C. § 360 (Federal Food, Drug, and Cosmetic Act) · 21 U.S.C. § 360E (Federal Food, Drug, and Cosmetic Act)

Relies on Celotex Corporation v. Catrett H · Matsushita Electric Industrial Co., Ltd. v. Zenith Radio Corporation · Erie Co v. Tompkins · Medtronic, Inc. v. Lohr · Dealers Transport Co. v. Battery Distributing Co.

Most-quoted passages

The sentences later courts lift from this opinion, ranked by how many decisions quote each — the parts of the opinion doing the work. These counts are smaller than the citation total above because most of the 7 citing decisions cite the case generally; a passage count includes only decisions quoting that exact language verbatim.

  1. “parrot[ing] the elements of a design-defect claim, utilizing buzz words and phrases such as 'in a defective and unreasonably dangerous condition,' 'unreasonably dangerous and more dangerous than an ordinary consumer would expect,' 'without substantial change in condition,' 'foreseeable risks exceeded the benefits associated,' [and] 'safer alternative designs' ...”
    1 later decision quote this exact passage · from the majority
  2. “[U]nder either theory, it is the legal duty of a manufacturer to use reasonable care to protect against foreseeable dangers. In a design defect case, courts use some form of risk-utility analysis to assess the decisions made by manufacturers with respect to the design of their products.”
    1 later decision quote this exact passage · from the majority
  3. “provides an exception to the general rule of strict liability for 'apparently useful and desirable product[s], attended with a known but apparently reasonable risk.'”
    1 later decision quote this exact passage · from the majority

How this case has been treated — in progress

Whether each later court followed, distinguished, criticized, or overruled this decision. The treatment classification (task #35) runs highest-cited cases first and lights up here as it reaches this one.